Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Immunitas
Biotech
BioMarin CEO replaces commercial chief—Chutes & Ladders
BioMarin CEO replaces commercial chief. Former FDA commissioner Gottlieb joins Comanche board. NextPoint taps former Moderna cancer scientist as CSO.
Max Bayer
,
Gabrielle Masson
Jan 19, 2024 8:30am
Agios replaces CEO after recent FDA nod—Chutes & Ladders
Jul 15, 2022 9:30am
2022 forecast: In biopharma talent wars, everybody has offers
Dec 22, 2021 3:00am
Bayer, Novartis-backed Immunitas gets $58M to test cancer drugs
Aug 18, 2021 6:00am